Preface; Contents; 1: Antibiotic Dosing During Continuous Renal Replacement Therapy (CRRT); 1.1 Introduction; 1.2 Pharmacokinetics and Pharmacodynamics of Antibiotics (Figs. 1.1, 1.2, and 1.3); 1.3 Variables Affecting the Elimination of Antibiotics in the CRRT; 1.4 Principles of Pharmacokinetics [20]; 1.4.1 Absorption; 1.4.2 Distribution; 1.5 Clearance Metabolism and Excretion; 1.6 Pharmacodynamics [20]; 1.7 Hemofiltration-Related Variables; 1.8 Basic Principles of CRRT (Fig. 1.4); 1.9 Hemofiltration; 1.10 Hemodialysis; 1.11 Hemodiafiltration; 1.12 Drug-Related Variables

1.13 CRRT and Various Classes of Antibiotics (Figs. 1.5, 1.6, 1.7, 1.8, 1.9, 1.10, 1.11, 1.12, and 1.13)1.13.1 Vancomycin; 1.13.2 Linezolid; 1.13.3 Daptomycin; 1.14 Beta-Lactamase; 1.14.1 Carbapenems; 1.15 Beta Lactamase-Inhibitor Combinations; 1.16 Cephalosporins and Aztreonam; 1.17 Fluoroquinolones; 1.18 Colistin; 1.19 Aminoglycosides; 1.20 Final Considerations (Figs. 1.14, 1.15, and 1.16); References; 2: Video Laryngoscope: A Review of the Literature; 2.1 Introduction; 2.2 Video Laryngoscopes; 2.2.1 GlideScope Verathon; 2.2.2 McGrath Aircraft Medical, UK; 2.2.3 C-MAC: Storz

2.2.4 Airway Scope Pentax2.2.5 King Vision Ambu; 2.2.6 Optical Laryngoscope Airtraq Airtraq; 2.3 The Video Laryngoscope in Emergency Medicine and Prehospital Setting; 2.4 Video Laryngoscopy in Patients with Unsecured Cervical Spine; 2.5 Video Laryngoscopy in Anesthesia; 2.6 Video Laryngoscope in the Obstetric Patient; 2.7 Video Laryngoscopy and the Obese Patients; 2.8 Video Laryngoscopy in Awake Intubation; 2.9 Video Laryngoscopy in the Pediatric Patient; 2.10 Discussion and Conclusions; Bibliography; 3: Lung Ultrasound in the Critically Ill Patient; 3.1 Introduction

3.2 Principles of Lung Ultrasound3.3 The BLUE Protocol; 3.4 Lung and Pleural Diseases; 3.4.1 Pleural Effusion; 3.4.2 Hemothorax; 3.4.3 Pneumothorax; 3.4.4 Pneumonia; 3.4.5 Alveolar Interstitial Syndrome; 3.4.6 COPD and Asthma; 3.4.7 Pulmonary Embolism; 3.5 Assessment of Diaphragmatic Motion; Conclusions; References; 4: Does High-Frequency Ventilation Have Still a Role Among the Current Ventilatory Strategies?; 4.1 Introduction; 4.2 The HFOV Technique; 4.3 HFOV: Recent Studies; 4.4 The "Difficult to Ventilate" Patient with ARDS (Fig. 4.5); References

5: Noninvasive Assessment of Respiratory Function: Capnometry, Lung Ultrasound, and Electrical Impedance Tomography5.1 Capnometry; 5.2 Practical Utility; 5.3 Lung Ultrasound in ICU; 5.3.1 Ultrasound Approach; 5.3.2 BLUE Protocol; 5.4 Diaphragm Ultrasound; 5.4.1 Assessment; 5.4.2 Diaphragmatic Sonography in ICU; 5.5 Electrical Impedance Tomography; 5.5.1 Theory; 5.5.2 How Thoraco-Pulmonary Application Works; Conclusions; References; 6: Protective Mechanical Ventilation in Brain Dead Organ Donors; 6.1 Introduction; 6.2 Epidemiology